Light imaging contrast agents
View Patent ↗The present invention relates to the use of particulate materials as contrast agents in in vivo light imaging.
1. Method of detecting lymph nodes of a human or non-human animal body by in vivo diagnostic light imaging, characterized in that a physiologically tolerable photo-labelled particulate contrast agent comprising gas-containing particles is administered into a lymph draining volume of said body, and wherein said body is illuminated with light of a wavelength in the range 600–1300 nm and an image is generated using detected light of a wavelength in the range 600–1300 nm.
2. A method as claimed in claim 1 , wherein said agent comprises chromophores or fluorophores.
3. A method as claimed in claim 2 , wherein said chromophore or fluorophore is bound to, coated on or contained or deposited within the gas-containing particle of the contrast agent.
4. A method as claimed in claim 3 , wherein said gas-containing particles are gas-containing liposomes.
5. A method as claimed in claim 2 , wherein said chromophore or fluorophore is selected from fluorescein and fluorescein derivatives and analogues, indocyanine green, rhodamine, triphenylmethines, polymethines, cyanines, phalocyanines, naphthocyanines, merocyanines, lanthanide complexes or cryptates, fullerenes, oxatellurazoles, LaJolla blue, porphyrins and porphyrin analogues and natural chromophores/fluorophores such as chlorophyll, carotenoids, flavonoids, bilins, phytochrome, phycobilins, phycoerythrin, phycocyanines, retinoic acid and analogues such as retinoins and retinates.
6. A method as claimed in claim 1 , wherein said detection comprises generation of a spatial image.
7. A method as claimed in claim 1 , wherein said detection comprises generation of a temporal image.
8. A method as claimed in claim 1 , wherein said detection comprises generation of a mono- or multi-dimensional image.
9. A method as claimed in claim 1 , wherein said contrast agent further comprises a targeting vector.